Cargando…
GATA1 Activity Governed by Configurations of cis-Acting Elements
The transcription factor GATA1 regulates the expression of essential erythroid and megakaryocytic differentiation genes through binding to the DNA consensus sequence WGATAR. The GATA1 protein has four functional domains, including two centrally located zinc-finger domains and two transactivation dom...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220053/ https://www.ncbi.nlm.nih.gov/pubmed/28119852 http://dx.doi.org/10.3389/fonc.2016.00269 |
_version_ | 1782492554499981312 |
---|---|
author | Hasegawa, Atsushi Shimizu, Ritsuko |
author_facet | Hasegawa, Atsushi Shimizu, Ritsuko |
author_sort | Hasegawa, Atsushi |
collection | PubMed |
description | The transcription factor GATA1 regulates the expression of essential erythroid and megakaryocytic differentiation genes through binding to the DNA consensus sequence WGATAR. The GATA1 protein has four functional domains, including two centrally located zinc-finger domains and two transactivation domains at the N- and C-termini. These functional domains play characteristic roles in the elaborate regulation of diversified GATA1 target genes, each of which exhibits a unique expression profile. Three types of GATA1-related hematological malignancies have been reported. One is a structural mutation in the GATA1 gene, resulting in the production of a short form of GATA1 that lacks the N-terminal transactivation domain and is found in Down syndrome-related acute megakaryocytic leukemia. The other two are cis-acting regulatory mutations affecting expression of the Gata1 gene, which have been shown to cause acute erythroblastic leukemia and myelofibrosis in mice. Therefore, imbalanced gene regulation caused by qualitative and quantitative changes in GATA1 is thought to be involved in specific hematological disease pathogenesis. In the present review, we discuss recent advances in understanding the mechanisms of differential transcriptional regulation by GATA1 during erythroid differentiation, with special reference to the binding kinetics of GATA1 at conformation-specific binding sites. |
format | Online Article Text |
id | pubmed-5220053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-52200532017-01-24 GATA1 Activity Governed by Configurations of cis-Acting Elements Hasegawa, Atsushi Shimizu, Ritsuko Front Oncol Oncology The transcription factor GATA1 regulates the expression of essential erythroid and megakaryocytic differentiation genes through binding to the DNA consensus sequence WGATAR. The GATA1 protein has four functional domains, including two centrally located zinc-finger domains and two transactivation domains at the N- and C-termini. These functional domains play characteristic roles in the elaborate regulation of diversified GATA1 target genes, each of which exhibits a unique expression profile. Three types of GATA1-related hematological malignancies have been reported. One is a structural mutation in the GATA1 gene, resulting in the production of a short form of GATA1 that lacks the N-terminal transactivation domain and is found in Down syndrome-related acute megakaryocytic leukemia. The other two are cis-acting regulatory mutations affecting expression of the Gata1 gene, which have been shown to cause acute erythroblastic leukemia and myelofibrosis in mice. Therefore, imbalanced gene regulation caused by qualitative and quantitative changes in GATA1 is thought to be involved in specific hematological disease pathogenesis. In the present review, we discuss recent advances in understanding the mechanisms of differential transcriptional regulation by GATA1 during erythroid differentiation, with special reference to the binding kinetics of GATA1 at conformation-specific binding sites. Frontiers Media S.A. 2017-01-09 /pmc/articles/PMC5220053/ /pubmed/28119852 http://dx.doi.org/10.3389/fonc.2016.00269 Text en Copyright © 2017 Hasegawa and Shimizu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Hasegawa, Atsushi Shimizu, Ritsuko GATA1 Activity Governed by Configurations of cis-Acting Elements |
title | GATA1 Activity Governed by Configurations of cis-Acting Elements |
title_full | GATA1 Activity Governed by Configurations of cis-Acting Elements |
title_fullStr | GATA1 Activity Governed by Configurations of cis-Acting Elements |
title_full_unstemmed | GATA1 Activity Governed by Configurations of cis-Acting Elements |
title_short | GATA1 Activity Governed by Configurations of cis-Acting Elements |
title_sort | gata1 activity governed by configurations of cis-acting elements |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220053/ https://www.ncbi.nlm.nih.gov/pubmed/28119852 http://dx.doi.org/10.3389/fonc.2016.00269 |
work_keys_str_mv | AT hasegawaatsushi gata1activitygovernedbyconfigurationsofcisactingelements AT shimizuritsuko gata1activitygovernedbyconfigurationsofcisactingelements |